Form 8-K - Current report:
SEC Accession No. 0001493152-24-025437
Filing Date
2024-06-27
Accepted
2024-06-27 16:15:22
Documents
14
Period of Report
2024-06-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41041
2 ex10-1.htm EX-10.1 217056
  Complete submission text file 0001493152-24-025437.txt   477391

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ards-20240624.xsd EX-101.SCH 3027
4 XBRL LABEL FILE ards-20240624_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ards-20240624_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3674
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38630 | Film No.: 241079455
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)